- Telehealth Visits
- Insurance plan information
Raymond K. Hsu, MD
Nephrology- Telehealth Visits
- Insurance plan information
Raymond K. Hsu, MD
Nephrology- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Raymond Hsu is a nephrologist who treats patients with a broad spectrum of kidney diseases, providing care in both inpatient and outpatient settings. In his clinic, he sees patients with all presentations of chronic kidney disease, difficult-to-control hypertension (high blood pressure), glomerulonephritis, pregnancy-related kidney diseases and other kidney disorders. He also treats patients with end-stage renal disease who are on long-term dialysis therapies, including hemodialysis and peritoneal dialysis.
Hsu's research uses administrative and clinical data to better understand which populations tend to be affected with acute and chronic renal diseases as well as their outcomes.
Hsu earned his medical degree from the Northwestern University Feinberg School of Medicine. He then completed a residency in internal medicine at the University of Washington School of Medicine, followed by a fellowship in nephrology at UCSF. He also has a master of advanced study degree in clinical research from UCSF.
Education & training
Board certification
- Nephrology, American Board of Internal Medicine/Nephrology
Fellowship
- Nephrology, University of CA at San Francisco School of Med
Residency
- Internal Medicine, University of Washington School of Medicine
Internship
- Internal Medicine, University of Washington School of Medicine
Degree
- MD, Northwestern University Feinberg School of Medicine
My expertise
Specialties
- Nephrology
Conditions
- Electrolyte Disorders
- Nephrotic Syndrome
- Lupus Nephritis
- Kidney Stone
- Renal Failure
- IgA Nephropathy
- Glomerulonephritis
Locations
My research
Clinical trials
Belimumab With Rituximab for Primary Membranous NephropathyOpens in a new window
Recruiting
. CR is defined as proteinuria of ≤ 0.3 g/day with a serum albumin ≥ 3.5 g/dL. PR is defined as a 50% or greater decrease in proteinuria compared to baseline…Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGNOpens in a new window
Recruiting
To demonstrate the superiority of iptacopan compared to placebo in reducing proteinuria at 6 months.
Publications
Showing 1-6 of 28 reviews
- December 8, 20255 out of 5 Stars
Dr. Hsu is an outstanding physician: very knowledgeable, compassionate and willing to. Connect with my other MD at UCSF to figure out a plan!
- November 20, 20255 out of 5 Stars
Dr. Raymond Hsu is an outstanding physician! He is always thoroughly prepared; he Is kind, friendly, very up-to-date on my medical history, drug Intake for my HTN, and my current physical status. Dr. Hsu Is always reassuring and encouraging to maintain my good eating regimen and medication regimen.
- September 19, 20255 out of 5 Stars
Dr. Hsu is a fantastic doctor! Smart, thorough and thoughtful and also friendly and kind. I've seen him many times and even had him perform a couple of kidney biopsies on me and he is always wonderful. When I had troubles with some of my earlier medicines that we tried, he worked hard to find one that worked for me. I'm grateful to have him as my kidney doctor.
- July 14, 20255 out of 5 Stars
Excellent doctor. I would highly recommend. Ease of Zoom meeting was excellent.
- July 10, 20255 out of 5 Stars
Professional, respectful and very kind.
- June 27, 20255 out of 5 Stars
The overall care that I get from Dr. Hsu is the best I have ever received from any doctor. He is the best.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.